Navigation Links
VetStem Biopharma is Happy to Announce Several of its Veterinary Clients have Surpassed the Centennial Mark by Performing VetStem Cell Therapy on over 100 Patients.
Date:5/20/2016

The leading Regenerative Veterinary Medicine Company, VetStem Biopharma., is proud to announce that 10 of its most experienced veterinary clients have treated over 100 of their own patients with the VetStem Cell Therapy. Each of these veterinarians has embraced this cutting edge technology to provide the highest level of care for their patients.

The veterinarians are Dr Ross Rich former owner of Cave Creek Equine Surgical Center- Phoenix, AZ now with Regenerative Medicine Consulting, Dr Martin Gardner of Western Performance Equine Ione, CA, Dr John McCarroll of Equine Medical Associates Pilot Point, TX, Dr Bill Hay of Tryon Equine Hospital Columbus, NC, Dr Scott Reiners of Mountain View Equine Hospital Steels Tavern, VA, Dr Kim Carlson of VCA Bay Area Veterinary Specialty San Leandro, CA, Dr Adam Gassel of Southern California Vet Specialty Hospital Irvine, CA, Dr Keith of Clement Burnt Hills Veterinary Hospital Burnt Hills, NY, Dr Jamie Gaynor of Peak Performance Veterinary Group Frisco, CO, and Dr Tim McCarthy of Cascade Veterinary Referral Center Tigard, OR. Several of these veterinarians have also presented their VetStem Cell Therapy patient outcomes at major veterinary conferences throughout the United States.

Stem cells are regenerative cells that can differentiate into many tissue types as well as being able to reduce pain and inflammation thus helping to restore range of motion and stimulate regeneration of tendon, ligament and joint tissues (http://www.vet-stem.com/science.php). In a study using VetStem Regenerative Cell Therapy on dogs with osteoarthritis of the hip joint it was found that regenerative cell therapy (adipose-derived stem cells) decreases patient discomfort and increases patient functional ability. VetStem Cell Therapy also demonstrated that the use of cell therapy promoted a better quality of healing for tendon and ligament injuries in horse with over 75% of horses treated returning to their prior performance level.

Once each of these veterinarians has identified a patient as a good candidate for stem cell therapy the procedure begins with a fatty tissue collection from the patient. The tissue sample is sent overnight to VetStem’s lab in California for processing. Once processed the stem cells are quality checked and then injectable doses of the patient’s stem cells are sent overnight, back to the veterinarian. Within 48hrs of collecting a fat sample from a patient they are able to inject stem cells into (arthritic or injured) affected areas and healing can begin.

VetStem would like to thank each of these veterinarians for their dedication and hard work in providing the highest level of care for their patients. We value our relationship with each veterinarian and are proud to be able to help them serve the animal community. We continue to strive to provide the highest quality services to our veterinary partners in order to provide the highest level of veterinary care. We know the human animal bond is an important part of our world today and strive to provide therapies that will give animals’ longer and better quality lives.

About VetStem Biopharma
VetStem Biopharma is a veterinarian-lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 14 years and 12,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13425865.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Shares News of the Successful Treatment of a Non-healing Chronic Wound and Rear Leg Lameness, with the New Pall V-PET™ Platelet Therapy System
2. VetStem Biopharma Announces OC Mobile Surgery now offers Stem Cell therapy for dogs and cats suffering from orthopedic conditions
3. New Book Out with Two Chapters on Veterinary Regenerative Medicine Written by Dr. Bob Harman, CEO for VetStem Biopharma, Now Available through Amazon
4. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to Speak at the International Canine Sports Medicine Symposium
5. Peak Performance Veterinary Group and VetStem Biopharma, Announce Educational and Clinical Partnership in Support of Local Area Veterinarians
6. VetStem Biopharma and PALL Life Sciences announce a clinical research/technology distribution agreement for Pall’s Veterinary Platelet Enhancement Therapy system V-PET™
7. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to Present at Third Annual Clinical and Surgical Translation of Stem Cells
8. Advanced Care Veterinary Services is Now Offering Stem Cell Therapy for Dogs and Cats in Conjunction with VetStem Biopharma
9. VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease
10. VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to be a Guest Speaker at MSC 2015 Adult Stem Cell Therapy & Regenerative Medicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 10, 2019 , ... ... network with the appointment of Biofeedback Tech Ltd as its authorised ... an essential part of many therapeutic treatments and clinical assessment protocols to treat ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve and ... scientific journals to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s portfolio ... more than 20 million articles, sourced from more than 15,000 journals. , “By ...
(Date:6/11/2019)... POWAY, Calif. (PRWEB) , ... June 11, 2019 ... ... parent company of Personalized Stem Cells Inc. (PSC) , has announced that ... of Public Health, Food and Drug Branch for manufacturing. This is an ...
(Date:6/6/2019)... ... , ... WCCT Global, Inc ., a full-service early phase contract research ... be receiving 3 awards at the 2019 CRO Leadership Awards, to be held on ... of overall Quality and Compatibility (Access to desired markets, cultural fit, timely project communications ...
Breaking Biology Technology:
(Date:5/23/2019)... ... May 23, 2019 , ... Catalent (Booth 3101), ... biologics and consumer health products, is to launch its new OneBio SuiteSM for ... International Convention, which takes place at the Pennsylvania Convention Center in Philadelphia, from ...
(Date:5/22/2019)... N.J. (PRWEB) , ... May 22, 2019 , ... ... custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical ... partnership agreement with Industrial Production Processes (IPP) Ltd has been ...
(Date:5/21/2019)... ... 2019 , ... Experiential tourism, a trend encompassing culinary travel, cultural exploration and ... And according to a recent report by Skift, a media company for the ... more travelers are wanting their journeys to be authentic and unique, and good cuisine ...
Breaking Biology News(10 mins):